Anthony N. Brady Professor of Pathology; Chair, Pathology; Chief of Pathology, YNHH, Pathology
Anthony N. Brady Professor of Pathology; Chair, Pathology; Chief of Pathology, YNHH, Pathology
Professor of Pathology and of Ophthalmology and Visual Science; Vice Chair, Pathology; Director, Anatomic Pathology, Pathology; CLIA Laboratory Director, Pathology; Medical Director, Pathology Informatics
Director, Anatomical Pathology
John Sinard is a board-certified anatomic pathologist. He received his bachelor's degree from Harvard University, and his M.D. and Ph.D. degrees from Johns Hopkins. His residency training was at Yale-New Haven Hospital. He is the Vice Chair of Pathology and Director of Anatomic Pathology and is active on the autopsy and surgical pathology services, with a specialty interest in ophthalmic pathology. He founded the Pathology Informatics Program, and has been developing software for over 30 years. His academic interests are centered on translational informatics: delivering modern data management tools to practicing physicians and researchers.
Dr. Adebowale Adeniran is an experienced surgical pathologist and cytopathologist, and currently Director of Cytopathology and the Cytology Laboratory. Dr. Adeniran obtained his MD degree from the University of Ibadan, Nigeria. He did his anatomic/clinical pathology residency at the University of Cincinnati Medical Center, followed by surgical pathology fellowship (with special interest in genitourinary pathology) at the University of Texas M.D. Anderson Cancer Center and cytopathology fellowship at the Memorial Sloan-Kettering Cancer Center. Dr. Adeniran is a practicing surgical and cyto pathologist, with a research focus on clinico-pathologic and molecular pathologic aspects of kidney cancer as well as thyroid cancer. He is a reviewer of several peer-reviewed journals including Thyroid, Acta Cytologica, Diagnostic Cytopathology and Cancer Cytopathology. He has authored more than 50 papers, 5 book chapters, and co-authored the textbook Common Diagnostic Pitfalls in Thyroid Cytopathology. He currently serves as Chairman, Publications and Newsletter committee of Papanicolaou Society of Cytopathology.
Director, Bone & Soft Tissue Pathology
After graduation from the United States Naval Academy at Annapolis in 1973, Dr. Laskin served two years on the destroyer, USS Corry (DD-817) as Gunnery Officer. He then earned his MD in 1979 from Jefferson Medical College in Philadelphia through the Navy Medical/Osteopathic Scholarship Program. Dr. Laskin completed his Anatomic and Clinical Pathology residency at Bethesda Naval Hospital (now known as Walter Reed National Military Medical Center) and was board certified in 1984. His Navy Medical Corps career included clinical leadership positions at the Armed Forces Institute of Pathology, the National Naval Medical Center, and Naval Hospital Japan, as well as faculty positions at the Uniformed Services University of the Health Sciences from 1990-1996. He was a member of the pathology faculty at Northwestern Feinberg School of Medicine in Chicago from 1996 to 2015, and served for a time as head of surgical pathology at Northwestern Memorial Hospital. Dr. Laskin joined the Pathology Department at Yale Medical School in 2015 as an Associate Professor.
Director, Breast Pathology
Dr. Reisenbichler completed a combined anatomic and clinical pathology residency at the University of Alabama in Birmingham in 2011 followed by breast and surgical pathology fellowships at Brigham and Women's Hospital in Boston. She was a member of the Pathology faculty at Vanderbilt University until 2017 when she joined the Pathology Department at Yale as an Assistant Professor.
Director, Bridgeport Pathology
Paul Cohen earned his MD at Columbia University in 1981. He completed his residency in anatomic pathology at Massachusetts General Hospital and the National Cancer Institute, where he also completed a pathology fellowship. Dr. Cohen is board certified in anatomic pathology. He is the Chair of Pathology at Bridgeport Hospital, and an Assistant Professor of Pathology at Yale School of Medicine. Dr. Cohen is the Director of the Yale Pathology residency program at Bridgeport Hospital.
Director, Finance and Administration
Director, Endocrine, Head & Neck Pathology
I am an Oncologic Surgical Pathologist by training with a life-long interest in cancers of the head and neck including salivary glands, thyroid, parathyroid and adrenal glands. Pathology allows me to study the underlying mechanism of disease, and guide treatment objectively, individualized to each patient. I am deeply committed to teaching and extending my expertise to patients and physicians. We started the Endocrine, Head & Neck subspecialty pathology program in 2009 dedicated to the detection of cancer, prediction of their behavior and response to therapy, often harmful to the patients and sometimes, to their families. Now the program has a complement of five surgical pathologists and an ACGME-accredited fellowship program and works in collaboration with molecular and cytopathology. I am fascinated by cancer cells, their persistence, immortality and lethality. My research includes head and neck melanomas arising in UV-light protected sites, e.g. oral and nasal mucosa, HPV-associated cancers of the head & neck, and the molecular mechanism of thyroid, parathyroid and adrenal tumors. Another interest of mine is public education through writing opinion pieces on common cancers in popular media.
Director, Genitourinary Pathology
Peter A. Humphrey, M.D., Ph.D. obtained his B.A. in Chemistry and Biochemistry, and his MD and PhD (in biochemistry) from The University of Kansas. He did his anatomic pathology residency at Duke University Medical Center, and joined the faculty there for four years, followed by 21 years as a faculty member at Washington University School of Medicine. Dr. Humphrey is a practicing surgical and urologic pathologist, with a research focus on clinico-pathologic and molecular pathologic aspects of prostate cancer. He is on the editorial boards of The American Journal of Surgical Pathology, Modern Pathology, and Human Pathology. He has published 246 papers, has authored the textbook Prostate Pathology, co-authored the textbook Gleason Grading of Prostate Cancer, co-authored the AFIP Fascicle on the Prostate, co-authored the textbook Neoplastic Mimics in Genitourinary Pathology, is co-editor of The Washington Manual of Surgical Pathology, and is co-editor of the 2016 World Health Organization book on Classification of Tumors of the Urinary System and Male Genital Organs . He is past President of the International Society of Urological Pathology and is immediate past President of The Arthur Purdy Stout Society of Surgical Pathologists. He has given lectures on 6 of the 7 continents.
Director, GI and Liver Pathology
Dr. Dhanpat Jain is a Professor of Pathology and Internal Medicine (section of Digestive Diseases). He is also the director of the program in gastrointestinal pathology at Yale. Dr. Jain graduated from Mysore Medical College, Mysore, India and received his M.B.B.S degree in 1986. He subsequently received his M.D. Pathology degree from Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India in 1991. He moved to the U.S. in 1995 and completed his Anatomic Pathology residency and Fellowship in Gastrointestinal Pathology at Yale University School of Medicine, and subsequently continued as a faculty there.
Dr. Jain is a nationally and internationally recognized gastrointestinal pathologist known for his diagnostic skills, research and teaching. He has more than 100 publications, many book chapters, books and reviews, all of which are largely in the field of gastrointestinal and liver pathology. He has delivered many lectures and participated in many courses at the national and international level. He is on the editorial board of several high impact journals in the field of gastrointestinal and liver disorders. His area of expertise is motility disorders of the gastrointestinal tract, for which he gets cases in consultation from across the globe. Dr. Jain is an accomplished teacher and has received many awards. He has continuously been nominated for “Best Doctors in America” for many years.
Director, Graduate Programs
Dr. Kyriakides completed a PhD at Washington State University in 1993. He did a postdoctoral fellowship at the University of Washington. His lab at Yale studies the the foreign body response to biomaterials and nanomaterials. In addition, Dr. Kyriakides studies nanomaterials and cell interactions with a focus on biosensing. Finally, ongoing efforts in the lab include engineering of tissue constructs to stimulate healing in mouse models of diabetes. He is Director of Graduate Studies for the Experimental Pathology PhD program. He also serves as a mentor for students from the School of Engineering and Applied Science.
Director, Gynecologic Pathology
Dr. Hui is Professor in the Department of Pathology and Department of Obstetrics, Gynecology and Reproductive Sciences at Yale School of Medicine. He received combined anatomic and clinical pathology residency training at Yale-New Haven Hospital in 2000, followed by Oncological Pathology Fellowship training at MSKCC. He joined the pathology faculty at Yale in 2001 and became full professor in 2013. Dr. Hui is a board certified surgical pathologist with clinical specialty areas including gynecologic pathology and molecular diagnostics. Currently, he is Director of Gynecologic Pathology Service and Clinical director of the Molecular Diagnostics Laboratory.
Dr. Hui oversees a dynamic, high volume gynecologic pathology service at Yale. One of his long-term academic goals is to build an outstanding gynecological pathology program with emphasis on diagnostic tissue evaluation, oncological biomarker identification and clinical applications, and understanding the pathogenesis of various gynecological cancers. Dr. Hui has particular clinical expertise in the diagnostic workup of gestational trophoblastic disease. He serves on the editorial boards of International Journal of Gynecological Pathology, Modern Pathology, Human Pathology and Journal of Clinical Pathology. He has authored over 200 publications and written three pathology textbooks including Cytology and Surgical Pathology of Gynecologic Neoplasms, Gestational Trophoblastic Disease: Diagnostic and Molecular Genetic Pathology, and Atlas of Intraoperative Frozen Section Diagnosis in Gynecologic Pathology. Dr. Hui was a member of the consensus and editorial working group for the 4th edition of WHO Blue Book of tumor classifications of female reproductive organs. Currently he is an expert member of the editorial board for the 5th edition of WHO Blue Book of GYN tumor classifications. In both editions of the WHO blue book, Dr. Hui is the responsible editor/author for the WHO classification of gestational trophoblastic disease. Dr. Hui serves on the Board of Directors of the International Society of Gynecological Pathologists (ISGyP) and is the treasurer of the society.
Director, Pediatric & Placental Pathology
Rafaella Morotti graduated from the University of Milan School of Medicine in 1982, where she also completed her residency in obstetrics and gynecology, and a fellowship in maternal-fetal medicine. She then completed her residency in anatomic pathology at Yale-New Haven Hospital, followed by a fellowship in pediatric pathology at New York University. She is board-certified in both anatomic and pediatric pathology. In 2016, Dr. Morotti was appointed Associate Director of the Pathology Autopsy Service.
Director, Quality and Safety, Bridgeport
Dr. Sanchez received his undergraduate degree at Fairfield University, his medical degree at SUNY Stony Brook, and did his residency in anatomic and clinical pathology at Yale New Haven Hospital. He worked as a community pathologist at the Hospital of Central Connecticut before joining the Pathology Department at Bridgeport Hospital. In addition to surgical pathology his interests include autopsy pathology, microbiology, medical education, medical history, and quality management.
Director, Renal, Cardiac & Transplant Pathology and EM Laboratory
Dr. Moeckel graduated magna cum laude from Ludwig Maximillians University in Munich, Germany. He trained in anatomic and clinical pathology at the University of Arizona, Tucson, AZ and was on faculty in the Department of Pathology at Vanderbilt University, Nashville, TN prior to his recruitment as Director of the Renal Pathology and Electron Microscopy Laboratory at Yale University. His academic interests are in clinical renal pathology and research of mechanisms of kidney injury repair and progression of chronic kidney disease. Dr Moeckel is a fellow of the American Society of Nephrology and a Diplomat of the American Board of Pathology. He has published numerous papers in peer reviewed journals and has received private industry and federal grants to support his research.
Dr. Stern earned a BS in Biology at MIT in 1976. He received a PhD in Biology in 1983 at University of California, San Diego, and the Salk Institute with S.I.T. Kennedy and Bart Sefton for dissertation research that elucidated the coronavirus lytic cycle. Dr. Stern returned to R.A. Weinberg’s lab at the MIT Cancer Center and Whitehead Institute for Biomedical Research in 1983. There, Dr. Stern’s postdoctoral work pioneered analysis of neu/ErbB2/HER2, an important human oncogene. As a Yale Pathology faculty member since 1988, Dr. Stern’s research has focused on the roles of eleven growth factors and four receptors of the EGF family in malignant transformation, especially in breast cancer, and he has also made significant contributions to the understanding of DNA damage response signaling pathways. Dr. Stern’s current work in breast cancer and melanoma includes developing approaches to countering rapid resistance to anti-cancer agents that target cancer signaling pathways. Dr. Stern is active in cancer training at Yale and in the Yale Cancer Center scientific leadership. He is co-leader of the Signal Transduction Research Program and Associate Director of Shared Resources of the Yale Cancer Center.
Director, Residency and Fellowship Programs
Dr. Kowalski is Director of the Anatomic and Laboratory Medicine Residency program at Yale. She is a board-certified in anatomic pathology and cytopathology. She received her M.D. from the Medical College of Georgia, and completed her pathology residency at Hartford Hospital. After completing a cytopathology fellowship at Yale-New Haven Hospital, she joined the faculty at Yale. Areas of interest include head and neck pathology, thyroid cytology, and graduate medical education.
Director, Thoracic Pathology; Director, Medical Studies
My major interests are in diagnostic and experimental lung pathology.
I entered the MD-PhD program at Yale School of Medicine in 1979. My PhD with Donal Murphy described a novel antigenic structure within the murine MHC. Upon graduation I trained in Anatomic Pathology under the supervision of Dr. Juan Rosai and simultaneously completed a post-doctoral fellowship with Richard Flavell, chair of the section of immunobiology, with a focus on T cell tolerance.
For many years, I worked on various murine models of inflammatory lung disease, ran an NIH funded morphology core for the Yale pulmonary section and ran a laboratory at West Haven VA looking at murine models of pulmonary fibrosis. I now still consult on various experimental models of lung disease and work with collaborators analyzing human fibrotic and neoplastic disease.
I am heavily involved in medical school curriculum development as Director of Medical Studies for Pathology, am on the curriculum committee and am Co-Director of one of the new master courses for the new (starting 2015) pre-clinical curriculum for YSM.
I have been Director of Anatomic Pathology at West Haven VA since 1994. I have been lead thoracic pathologist at Yale since 2004.